Clinical Trial

Parcel-guided rTMS for Major Depressive Disorder

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Study comparing standard repetitive transcranial magnetic stimulation (rTMS) for Depression to a novel targeting approach using brain surface parcellation to locate a specific brain target.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-13.
Trial Details
NCT Number NCT07287839
Lead Sponsor Soterix Medical
Collaborators: Columbia University
Conditions Treatment Resistant Depression (TRD)
Enrollment 60 participants
Start Date 2025-12-15
Primary Completion 2028-06-01 (estimated)
Study Completion 2028-06-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-18